Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NextCell Pharma publishes Interim Report 2 2021/2022

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 2 for the period September 1, 2021 – February 28, 2022 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Second quarter (2021-12-01 until 2022-02-28)● Operating income amounted to 1 840 (1 008) TSEK.● Operating result amounted to -10 212 (-8 149) TSEK.● Earnings per share* amounted to -

Nordnet AB (publ) – interim report January-March 2022

Nordnet today publishes its interim report for the first quarter 2022. The full report is available at www.nordnetab.com- The first quarter of the year was a dramatic period in several different ways. Naturally, Russia’s invasion of Ukraine placed humanitarian, political and financial considerations high on the agenda. Despite the challenging circumstances in the world, Nordnet’s operations developed positively during the quarter, with strong underlying growth. Net savings reach as high as SEK 21 billion and our loan portfolio achieved a new record high. In conclusion, with an adjusted

Orexo Interim Report Q1 2022

Promising start to 2022 Q1 2022 highlights · Total net revenues of SEK 159.4 m (132.3) · EBITDA of SEK 2.8 m (-23.9)  · Net earnings of SEK -23.6 m (-31.5) · US Pharma segment (ZUBSOLV® US) net revenues of SEK 139.1 m (126.8), in local currency USD 14.8 m (15.1), US Pharma EBIT of SEK 84.0 m (66.1) · Cash flow from operating activities of SEK -61.6 m (-47.8), cash balance of SEK 437.8 m (725.5) · Earnings per share before and after dilution amounted to -0.69 (-0.92) · Lead product ZUBSOLV® added to NY State Medicaid MAT Preferred Drug List as of March 22 · First

Interim report Q1, January - March 2022

Summary January - March 2022 • Net sales amounted to SEK 75.6 (70.4) million, an increase of 7.4 percent. In local currencies growth was 1.2 percent. • EBIT was SEK -0.2 (6.0) million, with an EBIT margin of -0.3 (8.5) percent. • Profit/loss after tax amounted to SEK 1.4 (6.5) million. • Earnings per share before/after dilution amounted to SEK 0.07 (0.35). • Cash flow from operating activities decreased to SEK 5.5 (9.4) million.CEO’s comments We notice an increased activity in the market and during the first quarter, MSAB has signed several strategically important

MIDSONA INTERIM REPORT JANUARY–MARCH 2022

Gradual improvement over the quarter supported by price increasesJanuary–March 2022 (first quarter) ● Net sales amounted to SEK 972 million (965). ● EBITDA amounted to SEK 62 million (92) and EBITDA, before items affecting comparability, amounted to SEK 62 million (94), corresponding to a margin of 6.4 percent (9.7). ● Operating profit amounted to SEK 22 million (54) and operating profit, before items affecting comparability, amounted to SEK 22 million (56), corresponding to a margin of 2.3 percent (5.8). ● Profit for the period was SEK 12 million (33), corresponding to earnings

Immunovia Publishes Interim Report January-March 2022

January-March · Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123) · Net earnings amounted to MSEK -44 (-23) and ear­nings per share before and after dilution were SEK -1.95 (-1.04) · Cash flow from operating activities amounted to MSEK -46 (-30) · Cash and cash equivalents at the end of the period amounted to MSEK 240 (425) · In February the peer-reviewed, blinded study to independently validate the clinical performance of IMMray™ PanCan-d was published in Clinical and Translational Gastroenterology · The

Polygiene AB (publ.) Interim Report January 1 – March 31, 2022

A solid start to the year with growth and restored profitabilityQ1 in brief (January - March 2022) · Net sales amounted to MSEK 45.1 (42.0), a positive growth by 7.5 % · The operating profit EBITDA amounted to MSEK 9.3 (9.8), corresponding to an EBITDA margin of 20.7 (23.4) % · The gross margin amounted to 67.1 (64.8) % · The cash flow amounted to MSEK 1.4 (31.0) Events during the quarter in brief (January - March 2022) · Polygiene acquires SteriTouch · MP Activewear boosts its training collections with Polygiene · Flowfresh updates antimicrobial flooring with

SBB sells properties in Norway, Finland and Sweden for SEK 2,500m

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) is selling seven properties in Norway, Finland and Sweden for an agreed property value of SEK 2,500m. Of these, SEK 2,280m is used to reduce net debt. The largest property in terms of value in the portfolio is Kunnskapsveien 55 in Lilleström in Norway with OsloMet as the largest tenant and other properties consist of public offices. Of the sales proceeds, NOK 1,850m comes from sales to Public Property Invest AS (“PPI”), where SBB owns 48.8 percent. In connection with the transaction, SBB will invest NOK 215m in PPI. After the transaction,

Q1 2022 Trading Update

International Personal Finance Q1 2022 trading update 28 April 2022 International Personal Finance plc specialises in providing unsecured consumer credit to 1.7 million customers through the world's largest home credit business and a leading fintech operator, IPF Digital Highlights · Good credit issued growth of 10%, driven by Mexico home credit and IPF Digital· Closing customer receivables of £713 million, up 14% year on year (at CER)· Revenue increased by 10% driven by growth in the receivables portfolio· Continued favourable collections performance and

Hexagon Composites ASA: Invitation to presentation of first quarter 2022 results

28 April 2022: Hexagon Composites ASA's first quarter results 2022 will be released on 12 May 2022 at 07:00 am CEST. Jon Erik Engeset, CEO and David Bandele, CFO will present the results at 08:30 the same morning. The presentation will be held in the Auditorium at Hexagon's location in Oslo, Haakon VIIs gate 2, on the lower level. If you would like to attend the presentation, please pre-register by emailing ir@hexagongroup.com, alternatively register upon arrival. The presentation will also be broadcasted live via: https://channel.royalcast.com/landingpage/hegnarmedia/20220512_4/. For

DNB Markets - VEF: Market volatility not new to VEF

VEF’s NAV declined only ~3% QOQ in Q1 despite turbulent markets. With a portfolio of leading fintech holdings across some of the world’s fastest-growing markets, the investment community now expects VEF to report only a ~7% IRR on invested capital (versus its 30% track record), as the stock is trading 47% below NAV. We have cut our fair value to SEK6.3–7.4 (6.8–8.1) on our updated NAV forecasts, to which we apply a 10% discount to NAV.Q1 takeaways: 1) VEF's NAV declined 3% QOQ in USD in Q1, as it marked down its Russian exposure to zero (all Russia-related potential downside now reflected),

Best start to a year – to date

The good development in 2021 continued into the first quarter of 2022. Inwido has increased net sales by 26% to SEK 2,073 million (1,644), while operating EBITA increased to SEK 180 million (121), which gives an operating EBITA margin of 8.7 % (7.3). Overall, this means that this is the best first quarter to date for Inwido.“The positive development from 2021 continued into the first quarter of 2022. Strong organic sales growth combined with active efforts to raise prices to counter higher input material prices resulted in Inwido’s best first quarter to date. During the quarter, we acquired

Boliden’s first quarter: High metal prices but substantial cost inflation

Revenues for the first quarter amounted to SEK 21,812 m (17,083) and operating profit, excluding revaluation of process inventory, totaled SEK 4,466 m (2,449). Free cash flow totaled SEK 674 m (2,165).“A strong quarter, with metal prices that remained high. Production was in general good with increased milled volumes at our mines and stable production at our smelters,” says Mikael Staffas, President and CEO.   The operating profit at Boliden Mines increased to SEK 3,115 m (1,631) due to improved metal prices and a stronger USD, while volumes had a negative impact. Costs increased as a

Interim Report 1 January – 31 March 2022

A successful quarter! AddLife´s interim report for Q1 2022 is now available online at the company website. The interim report can be downloaded in pdf version.Visit reports-en.add.life/interim-report-q1-2022 1 JANUARY – 31 MARCH 2022 (3 MONTHS) · Net sales increased by 49 percent to SEK 2,579m (1,736), of which acquired growth amounted to 51 percent. The organic growth, excluding net sales related to COVID-19, was 5 percent. The COVID-19 related net sales decreased by 25 percent. · EBITA increased by 34 percent to SEK 435m (326), corresponding to an EBITA-margin of 16.9

Interim report, January-March 2022

Best start to a year to dateFirst quarter 2022 · Net sales rose to SEK 2,073 million (1,644), up 26 percent. Organic growth amounted to 19 percent. · Reported order intake increased by 28 percent and the order backlog increased by 57 percent to SEK 2,311 million. · EBITA increased to SEK 177 million (121) and the EBITA margin increased to 8.5 percent (7.3). · Operating EBITA rose to SEK 180 million (121) and the operating EBITA margin rose to 8.7 percent (7.3). · Cash flow from operating activities increased to SEK 16 million (negative 75) · Return on operating capital

Bokusgruppen AB (publ) Interim Report January-March 2022

Earnings continue to improve, driven by a strong margin trend Quarter January-March 2022 · Net sales decreased 4.6% to MSEK 440.8 (461.9) · The gross margin was 36.4% (32.5) · EBITA improved to MSEK -0.4 (-2.4) · EBITA excl. items affecting comparability improved by MSEK 3.0 to MSEK -2.2 (-5.2) · EBITA LTM was MSEK 126.0 (81.1) · The Group’s net profit/loss improved by MSEK 4.6 to MSEK -10.6 (-15.2) · Earnings per share amounted to SEK -0.65 (-1.13) Significant events in the first quarter · The roll-out of a new IT platform, which will improve the integration

Q1 Interim Report 2022

Q1 2022 · Revenues totaled SEK 21,812 m (17,083)  · The operating profit totaled SEK 5,038 m (2,779) · The operating profit, excluding revaluation of process inventory, totaled SEK 4,466 m (2,449) · Free cash flow was SEK 674 m (2,165) · Earnings per share totaled SEK 14.51 (7.96)   High metal prices but substantial cost inflation · Free cash flow was SEK 674 m (2,165) mainly due to increased working capital as a result of higher metal prices. · Higher milled volume but lower grades in Mines. · Stable production in Smelters.   Please find enclosed the

Scandinavian Enviro Systems (publ) publishes Annual Report 2021

Scandinavian Enviro Systems’ Annual Report for 2021 is as of today, Thursday April 28 2022, available in Swedish on the company’s website https://www.envirosystems.se/en/investor/financial-information/.For further information, please contact: Thomas Sörensson, CEO of Enviro, +46 (0)735-10 53 43, thomas.sorensson@envirosystems.seUrban Folcker, Enviro CFO, +46 (0)760-00 13 11, urban.folcker@envirosystems.seAlf Blomqvist, Chairman of the Board of Enviro, +46 (0)733 149 700, alf@blomqvistunlimited.com Mangold Fondkommission AB, +46 (0)8 503 01 550, ca@mangold.se, is Enviro’s Certified

Lindab’s Interim Report January - March 2022: Record strong start of the year

Sales remained high during the first quarter and the adjusted operating margin was further strengthened. Both the Ventilation Systems and Profile Systems business areas reported strong organic sales growth and high profitability.First quarter 2022   As of 2022 Lindab’s business consists of business area Ventilation Systems and Profile Systems. Unless otherwise stated the comparative numbers exclude the divested business area Building Systems, which was divested in December 2021.   · Net sales increased by 30 percent to SEK 2,733 m (2,099). Organic growth was 23 percent. ·

SRV Group Plc has stopped the repurchase of own shares started on 3 February 2022

SRV GROUP PLC     STOCK EXCHANGE RELEASE    28 April 2022        8.35 EET SRV Group Plc has stopped the repurchase of own shares started on 3 February 2022 SRV Group Plc announced on 3 February 2022 that the Board of Directors had decided to start repurchasing a maximum of 3,900,000 own shares based on the authorization granted by the Annual General Meeting (AGM) on 29 March 2021. The Board of Directors has decided to stop the repurchase of own shares effective immediately. Between 7 February 2022 and 29 March 2022 SRV Group Plc repurchased 1,112,480 of its own shares at an

Evolution: Interim report January-March 2022

First quarter of 2022 (Q1 2021)  · Operating revenues increased by 38.6% to EUR 326.8 million (235.8) · EBITDA increased by 43.4% to EUR 229.7 million (160.1), corresponding to a margin of 70.3% (67.9) · Profit for the period amounted to EUR 197.7 million (132.0) · Earnings per share before dilution amounted to EUR 0.93 (0.62)  Events during the first quarter of 2022  · In the quarter 747,000 own shares were acquired. A total of 1,905,865 shares have been acquired and the repurchase program, announced 3 December 2021, is thereby completed. · Launch of Lightning

Hoist Finance interim report Q1 2022

Accelerated improvements “We have announced an agreement to divest the UK unsecured business, representing almost 20 per cent of the total loan portfolio, releasing between SEK 5 and 8bn in investment capacity. The divested business has had low returns during many years and a loss of SEK -169m during 2021. The continuing operation is improving. The comparable profit before tax increased for the quarter by 5 times, through increased collection performance and better loan portfolio quality” says Lars Wollung, CEO. January – March 2022 · Total operating income amounted to SEK 635m (

There are no items matching the current filter
There are no more items matching the current filter
Back to top